The REBIRTH trial is hoping to provide the definitive answer as to whether bromocriptine has additional benefits to women in addition to standard medical therapy. UK is one of 50 centers across the country participating in REBIRTH.
The fellowship empowers undergraduates to become leaders for their respective communities by providing opportunities to develop knowledge and skills through research within UK’s Research Priority Areas.
UK Research welcomed Monica Bertagnolli, M.D., the NIH director, to the Healthy Kentucky Research Building — a space dedicated to enabling multidisciplinary teams to find solutions to reduce the health disparities greatly impacting Kentucky.
Kenneth Campbell, from the UK College of Medicine, discusses how the establishment of the Gill Cardiovascular Biorepository has significantly advanced heart muscle research worldwide.
The American Society for Pharmacology and Experimental Therapeutics (ASPET) is honoring the University of Kentucky’s Vice President for Research for her foundational contributions to our understanding of the renin-angiotensin system that has broad implications for hypertension and cardiovascular disease.
UK will mark a decade of raising awareness and continuing its effort to warn women about the dangers of heart disease with the annual Healthy Hearts for Women Symposium.
The University of Kentucky will be home to a new research center focused on tobacco regulations in the Commonwealth named the Appalachian Tobacco Regulatory Science Team (AppalTRuST).
The five-year award is focused on comprehensive efforts to identify and respond to healthcare disparities in cardiovascular disease (CVD) and improve related outcomes.
